Delivery Order SPE2DB20D3303-SPE2DB24FA2GE

Award Date 8/21/24
Potential Completion Date 8/22/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,827.51 firm fixed price delivery order contract (SPE2DX15D1053|SPE2DX24F6QMX) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 360 MG/2.4 ML ON-BODY 2.4ML. This order is a component of Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $19,725.93 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide SKYRIZI 150 MG/ML PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $42,701.91 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the provision of the specialty pharmaceutical product SKYRIZI 150 MG/ML PENML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $16,267.41 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office division. The order is for the supply of SKYRIZI 150 MG/ML PENML pharmaceutical product. The award has an ultimate completion date of August 7, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and other healthcare...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of SKYRIZI 150 MG/ML PENML pharmaceutical product. The contract has a potential value of $18,678.07 and a completion date of February 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a $11,827.51 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is for the supply of the medication SKYRIZI 150 MG/ML PENML. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through 2025, which serves as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract is a firm-fixed price delivery order with a ceiling value of $47,103.62 and a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
The Department of Defense awarded a $23,725.77 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 150 mg/mL SKYRIZI pens. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a Delivery Order valued at $11,921.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 600 MG/10 ML VIAL 10ML, a specialty medication. The contract has a Firm Fixed Price pricing type and an ultimate completion date of September 5, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,844.70 firm fixed-price delivery order is for the supply of SKYRIZI 150 MG/ML PENML, a specialty medication. The contract has an ultimate completion date of January 13, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA2GE
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $24,181.90 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SKYRIZI 150 MG/ML PENML medication. This delivery order is placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 22, 2024. Amerisourcebergen, through its extensive pharmaceutical and medical supply chain, supports the healthcare needs of military personnel, veterans, and other federal beneficiaries across various locations and healthcare settings.

Generated 11/20/24, 9:12 AM